Safe and Effective Prescription of Controlled Substances
The prevalence of prescription drug use disorder is on the rise, including among patients previously considered low risk. This is especially true of opioid analgesics prescribed for chronic pain, stimulants prescribed for attention-deficit/hyperactivity disorder (ADHD), and benzodiazepines prescribed for anxiety or insomnia. In order to prevent the misuse of controlled substances and reduce the risk of substance use disorders, pharmacists and other healthcare providers should fully understand the different drug Schedules and their risks, carefully follow guidelines related to the prescribing and dispensing of substances within each Schedule, and consistently utilize state monitoring programs.
Identify the reason for the Controlled Substances Act (CSA) and state-specific regulations for the prescription of controlled substances
Describe the schedules of controlled substances according to their class or purpose, the relative risk for the misuse of each category of drug, and its potential for the development of substance use disorder
Compare and contrast the different types of controlled substances based on the accepted medical use and potential for misuse
Identify how Prescription Drug Monitoring Programs (PDMPs) can be used to help identify inappropriate drug use and prescribing
Identify best practices for reducing inappropriate controlled substance use while ensuring access in appropriate situations.
II. Controlled Substances Act and Other Regulations
1. Schedules of Controlled Substance
2. Stock Ordering of Controlled Substances
3. Storage, Recordkeeping, and Disposal of Controlled Substances
4. State-Level Scheduling and Regulations
5. Staying Up-to-Date
III. Drug Enforcement Administration (DEA)
IV. Prevalence of Prescription Drug Misuse
V. Prevention of Prescription Drug Misuse
1. Ensuring Appropriate Access
2. Basic Prescribing Best Practices
3. Basic Dispensing Best Practices
4. Implementation and Use of PDMPs
5. Case Example: Florida State Prescription Drug Monitoring
6. Drug Diversion and Doctor Shopping
VI. Safe Prescribing of Opioids
1. Indications for Opioid Pain Treatment
2. Special Considerations for Opioid Dispensing
3. Naloxone Case Example
VII. Opioid Use Disorder and Pain Management
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: Susan DePasquale, MSN, PMHNP-BC, Amanda Mayer, PharmD, and Jeff Goldberg, PharmD. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
- Target Audience: Pharmacist
- Contact Hours: 2.0
- Activity Release Date: 8/29/2022
- Activity Expiration Date: 8/29/2025
- Activity Type: Knowledge
- UAN: 0669-0000-22-009-H08-P
- Topic: Pain Management/Opioids
- CeBroker Number: 20-769565
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.